Determination of Factor V Leiden Mutation and R2 Polymorphism in Cis Position

被引：5
|
作者：
Ozturk, Aysenur [1 ]
Balli, Sezen [1 ]
Akar, Nejat [1 ]
机构：
[1] Ankara Univ, Pediat Genet Dept, TR-06100 Ankara, Turkey
来源：
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2013年 / 19卷 / 06期
关键词：
thrombosis; FV gene; mutation; polymorphism; ACTIVATED PROTEIN-C; 1691; G-A; VENOUS THROMBOSIS; TURKISH POPULATION; HR2; HAPLOTYPE; RISK; RESISTANCE; GENE; THROMBOEMBOLISM;
D O I：
10.1177/1076029612445916
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FVA4070G (R2 polymorphism) influences plasma factor V (FV) concentration and was associated with mild activated protein C resistance. This polymorphism was reported to have a trans inheritance with FV Leiden (FVL) mutation. The aim of this study is to investigate the inheritance of R2 polymorphism in the homozygous FVL carriers. In this study, 99 patients with thrombosis and 7 individuals without a history of thrombosis all of which homozygous for FVL were included. Of 99 patients, 1 was heterozygous for FV A4070G. Additionally, 6 polymorphisms in the FV gene were analyzed for the heterozygous R2 patient and her family. When the allelic distribution was classified, 8 different haplotypes were obtained. In contrast to the literature, it was shown that R2 polymorphism could be inherited in cis position with FVL and also the family members could have co-inheritance of the FVL and R2 on the same chromosome as proband.
引用
收藏
页码：685 / 688
页数：4
相关论文
共 50 条
  • [31] Factor V variants -: FV Leiden, FV R2 polymorphism (ex 13), FV Ddel polymorphism (int 16) -: Risk factors for venous thrombosis?: Results of a pilot study
    Schröder, W
    Konrad, H
    Grimm, R
    Schuster, G
    Herrmann, FH
    30TH HEMOPHILIA SYMPOSIUM, 2001, : 261 - 265
  • [32] Factor v Leiden mutation in cerebrovascular disease
    Buyru, N
    Altinisik, J
    Somay, G
    Ulutin, T
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (03) : 339 - 342
  • [33] Absence of factor V Leiden mutation in Koreans
    Kim, YW
    Yoon, KY
    Park, S
    Shim, YS
    Cho, HI
    Park, SS
    THROMBOSIS RESEARCH, 1997, 86 (02) : 181 - 182
  • [34] RACIAL VARIATION WITH FACTOR V LEIDEN MUTATION
    Ortega, Rosa M. Michel
    Hughes, Amy
    Munoz, Javier
    Jinadu, Adepeju
    Hanbali, Amr
    Kuriakose, Philip
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S78 - S79
  • [35] Factor V Leiden mutation and completed stroke
    Catto, A
    Carter, A
    Grant, PJ
    STROKE, 1996, 27 (03) : 573 - 573
  • [36] Factor V Leiden mutation in the Argentinian population
    Hepner, M
    Roldan, A
    Pieroni, G
    Frontroth, JP
    Serviddio, RM
    Torres, AF
    Sciuccati, G
    Bonduel, M
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (06) : 989 - 989
  • [37] Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice
    Bruggemann, Lois W.
    Schoenmakers, Saskia H. H. F.
    Groot, Angelique P.
    Reitsma, Pieter H.
    Spek, Arnold
    CRITICAL CARE MEDICINE, 2006, 34 (08) : 2201 - 2206
  • [38] PAI-1 promotor polymorphism: No relation to venous thrombosis and factor V Leiden mutation
    Spannagl, M
    Dick, A
    Schramm, W
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS397 - PS397
  • [39] Factor V Leiden mutation: a contributory factor for cerebral palsy?
    Reid, S
    Halliday, J
    Ditchfield, M
    Ekert, H
    Byron, K
    Glynn, A
    Petrou, V
    Reddihough, D
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (01): : 14 - 19
  • [40] Factor V Leiden mutation and factor II Leiden mutation in a healthy subject without thrombosis antecedent.
    Guermazi, S
    Bahlous, A
    Labbane, N
    Abdelhak, S
    Dellagi, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 380 - 380
12345